Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Oncol. 1996 May;8(3):221-6.

New drug therapy for squamous carcinoma of the head and neck.

Author information

  • 1Division of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN 37232-5536, USA.


The identification of new active agents for the treatment of squamous carcinoma of the head and neck remains a high priority for clinical investigators. For the past several years a number of investigational drugs have demonstrated activity in patients with recurrent or metastatic disease. Included are the following agents: gemcitabine, vinorelbine, paclitaxel, docetaxel, and ifosfamide. Further studies are underway to investigate the role of these agents in combination regimens. Randomized phase III trials comparing promising new regimens to standard therapy with methotrexate or cisplatin and 5-fluorouracil will be necessary.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk